SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Oliver & Co who wrote (4016)4/9/1998 11:52:00 PM
From: Bryan Arnold  Read Replies (1) of 6136
 
Nice Little Blurb in this week's Business Week. It commented that Agouron is a small-biotech with a big HIV Drug. Nothing new. Just pointed out that even though it only has 30% of the market as opposed to Crixivan's 35% it sells for more and thus is the number one selling AID's drug.

Commented then that it gets no respect for it. A small story about the Rodney Dangerfield syndrome.

Bryan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News